Sudarshan Pharma Board Approves ₹72 Crore Convertible Warrants Issue to Promoters
Sudarshan Pharma Industries Ltd · Others (Uncategorized) · 31 Oct 2026, 1:58 am
Sudarshan Pharma Board Approves ₹72 Crore Convertible Warrants Issue to Promoters Sudarshan Pharma Industries' Board approved raising up to ₹72 crore via the preferential issue and allotment of convertible warrants to promoters Mr. Hemal Mehta and Mr. Sachin Mehta on 29th Oct'26. Each warrant is convertible into one equity share of face value Re 1. The issue price will be determined under Regulation 164 of SEBI ICDR Regulations. The fundraise remains subject to regulatory and shareholder approvals at an upcoming Extraordinary General Meeting.
Original exchange filing (PDF)
More announcements from Sudarshan Pharma Industries Ltd
- Pursuant to Regulation 30 and other applicable Regulations, if any, of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we inform .... · 09 Nov 2026
- In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor .... · 07 Nov 2026
- This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to .... · 30 Oct 2026
- We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 · 30 Oct 2026
- We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 · 30 Oct 2026
- Sudarshan Pharma Industries Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Fund raising. · 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and Fund Raising · 29 Oct 2026
- Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve i) Unaudited Standalone .... · 29 Oct 2026
